Integrity Bio, Inc.

The primary objective of the study is to evaluate the efficacy and safety of VSA001 in Chinese adult patients with familial chylomicronemia syndrome (FCS).

To evaluate the safety and tolerability of VSA003 after a single subcutaneous (SC) injection and the PK/PD characteristics in healthy Chinese adult volunteers

A randomized, double-blind, placebo-controlled, single-dose Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of VSA001 injection in healthy adult volunteers in China.